NANETS Regional NET Education: The Multidisciplinary Management of NET Cancers

Saturday, March 16, 2019
7:30am – 4:00pm 

Registration

Registration will be opening soon.

Location

Scottsdale Marriott at McDowell Mountains
16770 North Perimeter Drive
Scottsdale, AZ 85260

Directions and parking information available here

Providers

Jointly Provided by Banner MD Anderson Cancer Center and North American Neuroendocrine Tumor Society.

Overview

Neuroendocrine tumors (NET) are considered to be a rare disease although the frequency of diagnosis has increased over the last ten years. As this is a rare disease, clinicians often do not know how to implement the appropriate care plan and until the last ten years there was great variability in terms of treatment. The diagnosis, treatment and management of NETs are time consuming, complex and require a multidisciplinary approach. Many healthcare providers who face these challenges are not adequately equipped in their knowledge or experience optimally manage NET disease.

The field of NET research has been evolving with new drug approvals and treatment modalities. In addition, experts in the field of NET disease have continued to develop strategies to improve diagnosis, treatment and management of NET cancers. It is through convening professionals in the areas of oncology, gastroenterology, pulmonology, surgery, radiology and allied fields that the awareness and understanding of NET diseases will expand, resulting in better treatment for NET patients.

Target Audience

This activity is designed for oncologists, gastroenterologists, pulmonologists, surgeons, radiologists, pathologists, primary care physicians, advanced practice nurses, nurses, physician assistants, pharmacists, fellows, students, and other allied health professionals involved with or interested in the treatment of patients with neuroendocrine tumors.

Learning Objectives

Upon completion of this activity, participants should be better able to:

  • Review current concepts of neuroendocrine tumor pathology, molecular profile, classification, and grading
  • Discuss the various diagnostic processes and use of current and emerging diagnostic tools to determine neuroendocrine tumor type
  • Summarize the current safety and efficacy data of the various surgical, medical and loco-regional approaches in the management of neuroendocrine tumors
  • Recognize the clinical features associated with carcinoid syndrome
  • Apply a multidisciplinary approach to the management of patients with neuroendocrine tumors
  • Review clinical trial data and ongoing studies evaluating novel management strategies for the treatment of neuroendocrine tumors

Program

7:30 - 8:00 am - Registration and Breakfast

8:00 - 8:10 am - Welcome and Opening Remarks - Boris Naraev, MD, PhD, FACP, Banner MD Anderson Cancer Center.

8:10 - 9:30 am - Overview of Neuroendocrine Tumors

Moderator: Boris Naraev, MD, PhD, FACP, Banner MD Anderson Cancer Center

  • Keynote Presentation: NETs -Background, Epidemiology, Classification, Biochemical  Diagnosis, Outcomes – Thomas O’Dorisio, MD, University of Iowa.
  • Pathology of NETs: General Characteristics, Grading, Staging, Sites--Ly T. Ma, MD, Banner MD Anderson Cancer Center
  • Imaging Modalities for Diagnosis and Follow-up: Anatomic and Functional imaging -  Susan Passalaqua, MD, Banner MD Anderson Cancer Center
  • Panel: Questions and Answers.

9:30 - 10:45 am - Surgical Treatment of NETs

Moderator: Madappa Kundranda, MD, PhD, FACP, Banner MD Anderson Cancer Center

  • Surgical principles in PNETs – Rodney Pommier, MD, Oregon Health & Science University
  • Surgical principles in SBNETs: Primary, nodes, metastases--- Rodney Pommier, MD, Oregon Health & Science University
  • Surgery for gastric, duodenal, and colorectal NETs - Rodney Pommier, MD, Oregon Health & Science University
  • Principles of Hepatic cytoreduction and Intraoperative Management of Carcinoid Crisis - Rodney Pommier, MD, Oregon Health & Science University
  • Panel: Questions and Answers

10:45 - 11:00 am - Break

11:00 - 11:30 am - Role of Hormones in NETs

  • Hormonal Syndromes in NETs; Clinical Specifics of functional PNETs - Thomas O’Dorisio, MD, University of Iowa
  • Symptom Control in NETs -- Boris Naraev, MD, PhD, FACP, Banner MD Anderson Cancer Center

11:30 - 12:30 pm - Medical Management of NETs

Moderator: Madappa Kundranda, MD, PhD, FACP, Banner MD Anderson Cancer Center

  • Overview of Agents used in NETs and Current Clinical Trials -- Thorvardur  Halfdanarson, MD, Mayo Clinic
  • Peptide radioreceptor therapy---Susan Passalaqua, MD Banner MD Anderson Cancer Center
  • Systemic Treatment of Progressive and Poorly-differentiated NETs— Heloisa Soares, MD, University of New Mexico
  • Panel: Questions and Answers session

12:30 - 1:30 pm Lunch and Networking 

1:30 - 2:30 pm - Additional Important Subjects in NETs

  • Hereditary syndromes with NETs: MEN1/2, VHL, Pheochromocytoma/Paraganglioma - Iram Ahmad, MD Banner MD Anderson Cancer
  • Pulmonary NETs: Clinical features, medical and surgical treatment – Thorvardur Halfdanarson, MD, Mayo Clinic
  • Liver-Directed treatments for patients with metastatic NETs - Andrew Price, MD, Banner MD Anderson Cancer Center

2:30 - 3:30 pm - Case Presentations and Multidisciplinary Tumor Board

Moderator: Madappa Kundranda, MD, PhD, FACP, Banner MD Anderson Cancer Center

Panel: Thomas O’Dorisio, MD, Thorvardur Halfdanarson, MD, Heloisa Soares, MD, Susan Passalaqua, MD, Andrew Price, MD, Boris Naraev, MD, PhD, FACP, Rodney Pommier, MD

3:30 pm - Closing Remarks - Boris Naraev, MD, PhD, FACP, Banner MD Anderson Cancer Center

Accreditation

Education credit information will be provided as it is approved.

Method of Participation

In order to meet the learning objectives and receive continuing education credit for this activity, participants are required to check in at the registration desk, attend the activity, and complete the online evaluation form at the conclusion of the activity. 

Registration

Online registration will open soon.

In-person registration available onsite on day of program and will be accommodated on a space-available basis

Registration fee:

NANETS Member
$65 - MD, PharmD, Doctoral Level 
$35 - Allied Health
Complimentary - Student/Fellow/Resident

Non-Member
$95 - MD, PharmD, Doctoral Level 
$50 - Allied Health
Complimentary - Student/Fellow/Resident

Cancellation Policy: A full refund will be made if registration is canceled, in writing, on or before March 11, 2019. On or after March 11, 2019, no refund will be made.

Banner MD Anderson Cancer Center and North American Neuroendocrine Tumor Society reserve the right to modify the activity content, faculty, and activities and reserve the right to cancel this activity if necessary. If the program is cancelled, liability is limited to the registration fee.

Questions?

Please contact us with any questions.